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1. INTRODUCTION 
Organisms have a tremendous capacity to adapt to environmental conditions. 
This requires not only immediate responses to acute alterations in the internal or 
external milieu but also mechanisms that allow experiences to shape the response to 
later stimuli. Together with its genetic background, it are the specific experiences 
and their long lasting consequences that model the individual. Aspects of this 
can be found in almost all cells and organs, and are most prominent in the central 
nervous system and the immune system. The immune system shows an amazing 
capacity to store information about pathogens to the extent that a first encounter can 
prevent the organism from becoming ill by a renewed contact with the pathogen 
for a lifetime. Information about a wide variety of experiences can be stored in 
the brain to affect the responses to later events. How this information is stored is 
still poorly understood, but synaptic plasticity is generally considered to play a crucial 
role. Not only during early development but also in adulthood single or sporadic 
exposure to particular environmental stimuli can affect the response to the same 
stimulus weeks to years later. Such a change in response as a result of a specific 
earlier experience is often denoted as the "priming" effect of the stimulus. In its most 
simple form, priming can result in a reduction of the response to a second encounter, 
a phenomenon called desensitization, habituation or tolerance. Alternatively, priming 
may lead to exaggerated responses upon renewed exposure, a phenomenon known 
as sensitization. Both habituation and sensitization of brain-mediated responses 
represent expressions of neuro-plasticity in the adult brain and plays a key role in 
physiological adaptations but also in the etiology of various psychiatric diseases 
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in particular of affective disorders. Habituation and sensitization of a wide variety of 
responses have been described including behavioral, metabolic, autonomous, neural, 
endocrine, and immune responses, and reflect altered vulnerability to a particular 
stimulus. In this chapter we will briefly describe long-lasting sensitization and cross-
sensitization to various stimuli as seen in adult animals, focus attention on immune 
activation induced long-lasting cross-sensitization, and discuss its possible contribution 
to the etiology of affective disorders. 
2. LONG-LASTING SENSITIZATION 
2.1. Sensitization to Stressors 
In experimental animals and in humans, single or sporadic exposure to certain 
stimuli including stressors, immune activation, and drugs of abuse can result in 
long-lasting (weeks-lifetime) sensitization. Although the information is scarce, the 
mechanisms underlying long-lasting sensitization may be different from sensitization 
seen during chronic or repeated stimulation (Antelman & Caggiula, 1996). In most 
chronic or repeated stress protocols that lead to sensitization, the neurochemical, 
behavioral, metabolic, and neuroendocrine responses undergo progressive alterations 
during stress exposure, and tend to return to their pre-stress profiles after cessation 
of the stress load (Van Dijken, 1992). Therefore, we and others have looked upon 
such chronic stress induced alterations as an effect of cumulation of rather short term 
effects (De Goeij, Binnekade, & Tilders, 1992a). Long-lasting sensitization by a 
single event follows a different pattern. For instance, exposure of adult rats to a single 
and short (15min) session of electric foot shocks induces behavioral sensitization 
to novel stressors, which progressively develops to reach a maximum approximately 
two weeks after the challenge (Van Dijken, Van Der Heijden, Mos, & Tilders, 
1992c), and can be maintained for two months as illustrated in Fig l.Thus, behavioral 
sensitization can develop in the absence of further stimuh. 
Because this pattern of behavioral sensitization is paralleled by sensitization 
of neuroendocrine and autonomic stress responses (Antelman, De Giovanni, & 
Kocan, 1989, Fig IB, IC), this form of long- lasting stress sensitization may reflect 
a state of increased stress vulnerability as seen in various psychiatric disorders 
(Akil & Ines Morano, 1995). In support of this, footshock-induced long-lasting 
behavioral sensitization was associated with increased anxiety related behavior, 
and anxiolytics were found to reverse these aberrant responses (Van Dijken, Mos, 
Van Der Heijden, & Tilders, 1992a; Van Dijken, Tilders, Olivier, & Mos, 1992b). Several 
other stressors including social defeat have been reported to induce alterations 
in behavioral and metabolic parameters that last for a week or more (Meerlo, 
Overkamp, & Koolhaas, 1997; Sherman & Petty 1982). Thus, although the effects 
of most stressors on subsequent responses dissipate within a few days, certain 
stressful events appear to provoke progressive and long-lasting alterations in stress 
responsive brain circuits that has precipitated in the "Once is enough" hypothesis (Van 
Dijken, 1992). 
There is a large body of literature on long-lasting effects of perinatal stress 
exposure on stress vulnerability, stress responses and changes in brain stress circuits. 
Collectively, these observations show that the developing organism is extremely 
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Figure 1. Long-lasting stress induced sensitization. Adult male rats were exposed to a single session of elec-
tric footshocks (shocked) or to the cage in which the shock was delivered without receiving electric current 
(control), and placed back in their home cage (Van Dijken et al., 1992a). At various time intervals thereafter 
(1 day-8 weeks) groups (n = 8) of shocked and control rats were exposed to a novel environment (noise test. 
Van Dijken et al., 1992a,b).Their behavior was recorded for 3min in the presence and absence of 65dB white 
noise, and animals were decapitated immediately thereafter (cf. Van Dijken et al., 1993). Panel A: behavioral 
immobility expressed as cumulative duration during the 3min noise off period. Panel B: plasma levels of 
ACTH at the end of the noise test. Panel C: numbers of fecal boluses produced during the noise test, which 
serves as an index of autonomic reactivity *p < 0.05; **p <4 0.01; ***p < 0.001 shocked vs time matched 
controls. 
sensitive in the sense that stress shapes the individual's responses to stressors in 
later life (Meaney, Diorio, Francis, Widdowson, Laplante, Caldji, Sharma, Seckl, & 
Plotsky, 1996; Weinstock, 1997). As discussed above, such long lasting sensitization is 
not an exclusive property of the developing brain. Also in adulthood certain stressors 
can affect stress responses and the underlying brain circuits for prolonged periods 
of time. 
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2.2. Sensitization to Drugs of Abuse 
Repeated exposure of experimental animals to drugs of abuse in particular 
to psychostimulants, can induce progressive and long-lasting (months) increases 
in behavioral responses induced by renewed drug exposure, and progressively 
increased motivational responses to obtain the drug. This "behavioral sensitization" 
to drugs of abuse is associated with lasting functional changes in certain brain circuits, 
i.e., mesolimbic dopamine systems (Kalivas & Steward, 1991; Robinson & Berridge, 
1993). In humans, it is believed that the development of similar long-lasting neuro-
plastic changes determine the individual's vulnerability to drug addiction and relapse 
after detoxification. Studies in rats have demonstrated that sporadic or even single 
administration of a psychostimulant such as amphetamine or cocaine can lead to 
sensitization of the motivational, locomotor, neurochemical, and neuroendocrine i.e. 
hypothalamus-pituitary-adrenal (HPA) responses to the drug weeks later (Antelman, 
Eichler, Black, & Kocan, 1980; MacLennan & Maier, 1983; Robinson, 1984; Wilcox, 
Robinson, & Becker, 1986; Paulson, Camp, & Robinson, 1991; Steward & Badiani, 1993; 
Schmidt, Tilders, Janszen, Binnekade, De Vries, & Schoffelmeer, 1995b; Schmidt, 
Tilders, Binnekade, Schoffelmeer, & De Vries, in press; De Vries, Schof-felmeer, Bin-
nekade, Mulder, & Vanderschuren, 1998). As for long-lasting sensitization to stressors, 
behavioral sensitization to drugs also appears to develop progressively in the absence 
of the stimulus. Several researchers demonstrated that neuroch-emical changes induced 
by chronic drug exposure show similarities with, but also differences from the long 
lasting changes seen after single or sporadic drug administration. This indicates 
that single and chronic drug administration can induce differential effects on the 
central nervous system. 
2.3. Sensitization to Immune Stimuli 
Activation of the immune system by pathogenic organisms or antigens leads to 
pathogen-specific responses of the immune system. In addition, immune stimuli elicit 
a host-defense response which is largely not pathogen specific. This non-specific illness 
response also occurs during tissue damage and inflammation and part of it is mediated 
by the brain. Thus, neuroendocrine, neurochemical, metabolic, and autonomic 
responses, and changes in mood, motivational state, sleeping patterns, eating behavior, 
social, and locomotor activities etc. all represent brain-mediated responses to illness 
(Kluger, 1991; Kent, Bluthe, Kelly, & Dantzer, 1992;Tilders, De Rijk, Van Dam, Vincent, 
Schotanus, & Persoons, 1994; Rothwell & Hopkins, 1995; Besedovsky & del Rey, 1996). 
The interest in these brain-mediated responses was boosted by the finding that endo-
toxins such as bacterial lipopolysacharide (LPS), and cytokines such as tumor necrosis 
factor alpha (TNF), interleukin-1 (IL-1), and IL-6 mimic most if not all of the brain-
mediated symptoms of illness induced by pathogens and inflammatory stimuli. How 
these large molecular cytokines, that cannot readily pass the blood-brain-barrier, affect 
the brain is still not fully understood but may involve neural afferents (Watkins,Wierte-
lak, Goehler, Mooney-Heiberger, Martinez, Furness, Smith, & Maier, 1994; Gaykema, 
Dijkstra, & Tilders, 1995; Rivest, 1995; Sehic & Blatteis, 1996; Maier, Goehler, Fleshner, 
& Watkins, 1998) and humoral mechanisms (Van Dam, De Vries, Kuiper, Zijlstra, 
Tilders, & Berkenbosch, 1996; Tilders et al., 1994; Rivest, 1995; Ericsson, Liu, Hart, & 
Sawchenko, 1995; Ericsson, Arias, & Sawchenko, 1997). 
A prominent symptom of illness is activation of the hypothalamus-pituitary-
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adrenal (HPA) system, which results in elevated plasma concentrations of adrenal 
glucocorticoids (Cortisol, corticosterone). Because glucocorticoids exert potent 
anti-inflammatory activity and in general inhibit the production and effects of 
proinflamatory cytokines and other mediators, increased corticosterone levels are 
considered to play a crucial role in restraining the host-defense response. In its most 
typical form, immune activation by single administration of endotoxin, IL-1, IL-6 or 
TNF leads to transient activation of the HPA-system which, dependent on dose and 
route of administration, dissipates within 6-24 hours. After chronic administration 
of these cytokines, plasma ACTH, and corticosterone levels are initially elevated 
but progressively fall in time, which may point towards desensitization of the 
HPA system (Van der Meer, Sweep, Pesman, Tilders, & Hermus, 1996). In an 
acute model of experimental allergic encephalomyelitis, which is a T-cell and 
macrophage mediated autoimmune response corticosterone levels increase in 
parallel with the severity of the neurological symptoms and normalize after their 
disappearance (MacPhee, Antoni, & Mason, 1989). Experimental models of chronic 
inflammatory diseases such as adjuvant-induced arthritis show chronic activation 
of the HPA system (Sarlis, Chowdrey, Stephanou, & Lightman, 1992; Harbuz & 
Lightman, 1992) and reduced responses to stressors (Shanks, Harbuz, Jessop, Perks, 
Moore, & Lightman, 1998). Thus, chronic immune stimulation may lead to desensitiza-
tion of ongoing HPA responses. 
In contrast, short immune activation by single administration of IL-1 to adult rats 
can increase the HPA response to a second stimulus one to two weeks later, showing 
that a single exposure to this immune stimulus induces long-lasting sensitization of the 
HPA response (Schmidt, Janszen, Wouterlood, & Tilders, 1995a). Similar long-lasting 
(1-12 weeks) sensitization of the HPA response to IL-2 has been reported in humans 
(Denicoff, Durkin, Lotze, Quinlan, Davis, Listwak, Rosenberg, & Rubinkow, 1989). 
Whether or not long lasting IL-1 induced sensitization of the HPA axis is associated 
with sensitization of other brain mediated host-defense responses is not clear 
(Anisman, Kokkinidis, Borowski, & Merali, 1998). Preliminary findings do not show 
lL-1 induced long-lasting sensitization of the febrile response. In fact, this is not 
surprising because glucocorticoids are known to suppress the febrile response to IL-1 
and other immune stimuli (Watanabe, Makisuma, Tan, Nakamori, Hakaura, & 
Murakami, 1995).Therefore, exaggerated corticosterone responses may mask possible 
sensitization of brain mechanisms driving febrile or other illness responses. Alterna-
tively, it is not inconceivable that immune activation induces long-lasting sensitization 
of some but not of other host-defense responses. 
3. LONG-LASTING CROSS-SENSITIZATION 
Long-lasting cross-sensitization of behavioral responses has been extensively 
described for drugs and stressors (Antelman et al., 1980; MacLennan & Maier 1983; 
Wilcox et al., 1986; Robinson, Becker, Young, Akil, & Castaneda, 1987). Here, we will 
focus on cross-sensitization of HPA responses. As described in section 2, stimuli of a 
widely different nature can induce long-lasting sensitization of the HPA system, i.e., 
lead to exaggerated ACTH and corticosterone responses upon renewed exposure to 
the same or a similar stimulus. Interestingly, sensitization may also lead to exaggerated 
HPA responses to stimuli of a different nature, a phenomenon denoted as "cross-
sensitization". For example, single administration of IL-1 to adult rats not only 
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enhanced ACTH and corticosterone responses to IL-1, but also to electric foot shocks 
(Schmidt et al., 1995a) and amphetamine (Schmidt et al., in press). Similarly, electric 
foot shocks induce long lasting sensitization of the ACTH response to a novel envi-
ronment (fig IB, Van Dijken, De Goeij, Sutanto, Mos, De Kloet, & Tilders, 1993) and 
cross-sensitization of the HPA response to amphetamine (Schmidt et al., in press). This 
is not to say that long-lasting sensitization is always associated with cross-sensitization 
of the HPA system to other stimuli. Nonetheless, available data indicate that single 
exposure of rats to IL-1 is particularly powerful in increasing HPA responses to 
immune stimuli, emotional stressors, and psychostimulant drugs for prolonged periods 
of time (weeks), and leads to the concept that transient immune activation can alter 
the individual's HPA response to stressors, and therefore affect its stress-vulnerability 
for prolonged periods of time. 
4. IMMUNE-INDUCED LONG-LASTING CHANGES IN 
THE HPA SYSTEM 
Let us consider the changes in the biological substrate that may underlie such 
long-lasting cross-sensitization. Because largely different brain circuits are involved in 
the activation of the HPA system by immune and emotional stressors (Sawchenko, 
Brown, Chan, Ericsson, Li, Roland, & Kovacs, 1996), it was obvious to search for func-
tional alterations within the HPA system rather than in stressor-responsive neural 
projections to the PVN. So far, long lasting alterations have been found at the level of 
the hypothalamic CRH neurons, of the pituitary gland and in feedback mechanisms. 
Before going into details of these changes it should be noted that single immune 
activation induces little or no long-term alterations in the resting levels of ACTH and 
corticosterone in the blood or the content of these hormones in the pituitary gland and 
adrenal gland respectively. Therefore, immune induced sensitization of the HPA system 
appears to be associated with altered responsivity rather than with altered resting 
activity of the HPA system. 
Corticotropin Releasing Hormone (CRH) producing neurons situated in the 
parvocellular part of the paraventricular nucleus (PVN), are activated by IL-1 and play 
a crucial role in IL-1 induced ACTH and corticosterone secretion (Berkenbosch, Van 
Oers, Del Rey, Tilders, & Besedovsky, 1987; Rivest 1995; Ericsson et al., 1995; Gaykema 
et al., 1995). In collaboration with Aguilera's group in Bethesda, we found that 1-2 
weeks after IL-1 priming, CRH neurons showed little or no changes in the expression 
levels of CRH mRNA, CRH peptide stores and CRH turnover (Schmidt et al., 1995a; 
Tilders et al., in prep). Another peptide that plays a prominent role in the control of 
ACTH secretion is vasopressin (AVP), which strongly potentiates the ACTH releasing 
effect of CRH. Although AVP is also produced by magnocellular neurons of the PVN 
and secreted from terminals in the posterior pituitary gland, various arguments support 
the view that AVP secreted from parvocellular CRH neurons represents the major 
potentiator of CRH mediated ACTH secretion (Whitnall, 1993; Kovacs & Sawchenko 
1996). In rodents and humans, hypothalamic CRH neurons can occur in two pheno-
types (Whitnall, 1993; Raadsheer, Sluiter, Ravid, Tilders, & Swaab, 1993; Raadsheer, 
Tilders, & Swaab, 1994b). Under resting conditions, only part of these CRH neurons 
belong to the AVP co-producing phenotype, i.e., co-express AVP mRNA, co-produce, 
co-store, and co-secrete AVP with CRH (De Goeij et al., 1992a; De Goeij, Dijkstra, & 
Tilders, 1992b; Whitnall, 1993; Bartanusz, Jezova, Bertini, Tilders, Aubry, & Kiss, 1993). 
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In collaboration with Verwer in Amsterdam, we found that the numbers of presumed 
CRH neurons that express AVP mRNA had increased 1-2 weeks after IL-1 priming. 
This is in accordance with an increase in the fraction of CRH terminals that co-store 
AVP (Schmidt et al., 1995a) and shows that IL-1 induces long-lasting changes in the 
phenotypic expression of CRH neurons. Moreover, following a single IL-1 challenge, 
terminals of CRH neurons in the median eminence showed a delayed (>4 days) but 
long lasting (1-3 weeks) increase in AVP stores as illustrated in Fig 2. Therefore, the 
composition of ACTH secretagogues that are produced by hypothalamic CRH neurons 
is altered for prolonged periods of time after a single IL-1 exposure (Tilders & Schmidt, 
1998). Peptide turnover studies (Schmidt et al., 1995a) further support the view that 
the signal which is produced by hypothalamic CRH neurons, had shifted towards AVP 
domination which is reminiscent of changes found after adrenalectomy, chronic stress 
(Whitnall, 1993; Tilders, Schmidt, & De Goeij, 1993; Aguilera, 1994), and depression 
(see below). 
At the level of the pituitary gland, IL-1 priming did not affect steady state 
levels of POMC mRNA, POMC hnRNA, CRH receptor mRNA, and of CRH and 
vasopressin receptors (Tilders et al., in prep). However, alterations were disclosed when 
IL-1 primed animals were challenged to mount an ACTH response. In vivo studies 
revealed that IL-1 priming increased the ACTH response to an AVP challenge but 
attenuated the ACTH response to CRH. Thus, although the levels of CRH receptors 
and CRH receptor mRNA and their kinetics in the pituitary gland seem relatively 
intact, CRH effects in the pituitary gland are suppressed, which may hint to alterations 
in post-receptor mechanisms. Re-exposure of IL-1 primed rats to IL-1 revealed 
that the rapid down regulation of AVP receptors as seen in vehicle-primed animals 
was obliterated (Tilders et al., in prep). Thus, the mechanisms that appear to 
terminate AVP signaling in the pituitary gland are shut down in IL-1 primed animals, 
and AVP signaling is enhanced. The alterations in the pituitary gland therefore 
do not seem to compensate for the increased AVP drive by hypothalamic CRH 
neurons, but rather amplify the impact of enhanced AVP exposure during the challenge 
(see Fig 3). 
In vivo studies further demonstrate that resting and stressor induced plasma 
days 
Figure 2. Long-lasting immune stimulus induced effects on hypothalamic CRH neurons. Adult rats were 
given a single dose of human recombinant interleukin-1 (IL-1) or vehicle (control). At various time inter-
vals thereafter (1-40 days) hypothalami of IL-1 primed and vehicle primed rats (n = 8) were processed for 
quantitative immunocytochemical determination of CRH and vasopressin (AVP) in the external zone of the 
median eminence (terminals of hypophysiotropic CRH neurons). Note the delayed (>4 days) and long lasting 
(7-20 days) increase in AVP signal. *p < 0.05; **p < 0.01 vs vehicle primed time-matched controls. For details 
see: Schmidt et al., 1995a. 
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Figure 3. Schematic representation of immune-activation induced long-lasting alterations in hypothalamic 
CRH neurons and pituitary corticotrophs. PVN: paraventricular nucleus of the hypothalamus where cell 
bodies of hypophysiotropic CRH neurons are located. ZEME: external zone of the median eminence where 
the terminals of these neurons are located. Receptor mechanisms for CRH and AVP signaling are depicted 
as VIb and CRH-1 respectively. For details see text. 
corticosterone levels of IL-1 primed rats were less sensitive to the suppressive actions 
of dexamethasone as compared to those in non-primed animals (Tilders et al., in prep), 
which reflects a partial glucocorticoid feedback deficiency for prolonged periods of 
time. The underlying processes may relate to alterations in glucocorticoid receptor 
mechanisms in the pituitary gland and/or the brain. Alternatively, because AVP-
mediated ACTH secretion as compared to CRH-mediated ACTH secretion is rather 
insensitive to glucocorticoid inhibition (Abou-Samra, Catt, & Aguilera, 1986; Aguilera, 
1994), this may as well be a reflection of the increased contribution of AVP to the 
control of ACTH secretion. 
Although alterations at other levels cannot be excluded, the present findings 
strongly support the concept that long lasting alterations in hypothalamic CRH 
neurons and in pituitary corticotrophs are instrumental in IL-1 induced long-lasting 
sensitization of the HPA system. 
5. STIMULI INDUCING CROSS-SENSITIZATION AND 
NEUROPLASTICITY 
In view of the above mentioned findings, we studied whether a similar relation-
ship between long-lasting cross-sensitization and neuroplastic changes in hypothalamic 
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CRH neurons as induced by IL-1 also occurs after other stimuli. In other words, do 
different stimuli that induce long-lasting cross-sensitization of HPA responses, all 
induce similar neuroplastic changes in hypothalamic CRH neurons and vice versa? This 
is most probably not the case. Let us consider the effects of different manipulations of 
adult male rats on AVP stores in CRH terminals in the median eminence as an index 
of AVP hyperproduction in CRH neurons. As summarized in Table 1, various stimuli 
lead to increased AVP stores 1-3 weeks after the primary event, whereas other stimuli, 
including cocaine (Schmidt et al., 1995b), amphetamine (Schmidt et al., in press) novel 
environment, ether, restraint, insulin induced hypoglycemia (Schmidt, Binnekade, 
Janszen, & Tilders, 1996), road transport from the animal supplier facilities to our labs 
(unpublished observations), and social defeat (Buwalda, De Boer, Schmidt, Sgoifo, Van 
Der Vegt, Tilders, Bohus, & Koolhaas, in press) do not. 
Earlier, we proposed that the power of the stimulus as reflected in the overall 
ACTH secretion (amplitude and duration) may determine long-lasting AVP hyper 
production in CRH neurons (Schmidt et al., 1996). Some novel observations are at odds 
with this view. For instance, social defeat which is a very strong stimulus for the HPA 
system (Buwalda et al., in press), does not affect AVP stores in CRH neurons. Based 
on all presently available data (see Table 1) we hypothesize that possibly not the inten-
sity, but rather the nature of the stimulus primarily determines whether hypothalamic 
CRH neurons will increase their AVP production for prolonged periods of time and 
thereby produce an intrinsically more powerful ACTH releasing signal. 
Conditions that did result in long-lasting increases in AVP stores in CRH neurons 
include inflammatory stimuli that can stimulate the production of cytokines in the 
brain. For instance, peripheral administration of endotoxin has been reported to result 
in lL-1 expression in the brain (Van Dam, Bauer,Tilders, & Berkenbosch, 1995; Buttini 
& Boddeke, 1995; Gabellec, Griffais, Fillion, & Haour, 1995; Salta, Jacobs, Kaltsas, & 
Table 1. Long-lasting effects of various stimuli on CRH neurons and HRA sensitization. 
Adult male rats were subjected to a single exposure to one of various stimuli or to control 
conditions. Changes in CRH and AVP stores in CRH terminals in the external zone of the 
median eminence (ZEME) were measured 1-3 weeks later by quantitative 
immunocytochemistry (cf Schmidt et al., 1996). In separate experiments, groups 
of rats were exposed to a challenge of the same nature 1-3 weeks after the 
priming stimulus and ACTH and/or cort responses were monitored 
Peptide stores in Z E M E 
Stimulus CRH AVP Sensitization of HPA-response 
Footshocks —> 
IL-I i.p. ^ / T T t 
IL-l i.c.v. -^ T 
Brain surgery -> T 
LPS i.p. -^ t 
Social defeat —> -^ T 
Hypoglycaemia -> -^ '.' 
Restraint -^ —> ? 
Ether -^ ^ -^ 
Road transport ^ 1 ) -> 1) 2) 
Cocaine —> -^ T 
Amphetamine -> ^ T 
-^: no change; T: increase; ? not determined; 1) control groups were sacrificed at the animal suppliers facilities; 2) all animals 
have this history. For references see text. 
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Grossman, 1998). Similarly, peripheral and central administration of IL-1 has been 
reported to increase IL-1 transcription in the brain (Plata-Salaman & Ilyin 1997; 
Hansen, Taishi, Chen, & Krueger, 1998) and also brain injury/surgery is known to 
induce local IL-1 transcription (Fan, Young, Barone, Feuerstein, Smith, & Mcintosh, 
1995). Under certain experimental conditions, also electric foot shocks can induce 
IL-1 protein in the brain (Nguyen, Deak, Owens, Kohno, Fleshner, Watkins, & Maier, 
1998). Therefore, we speculate that cytokines that are produced in the brain in response 
to these stimuli may play a role in the cascade of events that result in long-lasting 
changes in the phenotype of hypothalamic CRH neurons. 
6. D E P R E S S I O N - A S S O C I A T E D A L T E R A T I O N S IN 
T H E H P A SYSTEM 
Functional changes often referred to as dysregulations of the HPA system have 
been extensively documented in patients with depression (Akil & Ines Morano, 1995; 
Post & Weiss, 1995; Holsboer & Barden, 1996). These include increased episodes of 
ACTH and Cortisol secretion, elevated mean Cortisol levels in the blood and increased 
free urinary Cortisol levels. Various observations from both clinical and experimental 
animal studies support a causal link between dysregulation of the HPA system and psy-
chopathology. Increased episodes of enhanced Cortisol levels will lead to overexposure 
of the brain to this glucocorticoid and will affect the functioning of limbic forebrain 
structures including the hippocampus that are involved in processing of cognitive 
stimuli and the regulation of mood, learning, and memory processes, as well as 
aminergic systems in the brain stem that play a role in arousal and appraisal of 
environmental stimuli (De Kloet & Joels, 1996; Joels, 1997). Glucorticoid induced 
alterations in the functioning of these brain structures as seen in chronic stress and 
depression in turn, are believed to facilitate activation of hypothalamic CRH neurons, 
and thereby sustain enhanced Cortisol exposure (McEwen & Sapolsky, 1995). There is 
an ongoing debate as to the initial changes that drive the hyperactivity of the HPA 
system in depressed patients. One of the hypotheses concerns an acquired or inherited 
glucocorticoid feedback resistance (De Kloet, Vreugdenhil, Oitzl, & Joels, 1997). In 
accordance with this hypothesis, deficient Cortisol responses to dexamethasone have 
been reported in up to 50% of patients with major depression. The finding that 
relatives of depressed patients that are at genetic risk for developing the disease, show 
excessive Cortisol responses in combined dexamethasone/CRH tests (Holsboer, Lauer, 
Schreiber, & Krieg, 1995) further supports the view that disturbances of glucocorticoid 
feedback (which is crucial for the normal functioning of the HPA system) represent a 
risk factor for the development of depression (Young, Haskett, Murphy-Weinburg, 
Watson, & Akil, 1991). In addition, increased AVP production and secretion by 
hypothalamic CRH neurons which is known to occur in depression (see below) may 
generate a less glucocorticoid suppressible signal for ACTH release (Aguilera 1994, 
Von Bardeleben, Holsboer, Stalla, & Muller, 1985). 
CRH provocation studies in depressed patients revealed blunted ACTH but 
normal Cortisol responses relative to controls. It is reasoned that the defective ACTH 
response may be due to reduced CRH receptor efficacy. Alternatively, elevated 
Cortisol levels may account for the blunted ACTH response by their feedback action 
at the pituitary gland (Von Bardeleben, Stalla, Muller, & Holsboer, 1988).The dissoci-
ation of ACTH and Cortisol responses to a CRH challenge points to yet another level 
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of dysregulation in the system. Together with enhanced Cortisol responses to ACTH, 
these findings indicate that adrenal glands of depressed patients are hyper-responsive 
to circulating ACTH. In support of this, computer tomography studies revealed 
adrenal enlargement in major depressed patients (Nemeroff, Krishnan, Reed, Leder, 
Beam, & Dunnick, 1992) which disappears after successful treatment (Rubin, Phillips, 
Sadow, & McCracken, 1995). What exactly controls the changes in adrenal volume and 
responsiveness is not known but non-ACTH mechanisms including intra-adrenal CRH 
production (Van Oers, Hinson, Binnekade, & Tilders, 1992) and increased sympathetic 
drive (Dijkstra, Binnekade, & Tilders, 1996) are potential candidates. 
In major depression, dysregulation of the HPA system is associated with increased 
activity of hypothalamic CRH neurons. This is supported by increased CRH concen-
trations in the CSF of depressed patients (Nemeroff, Widerlov, Bissette, Walleus, Karls-
son, Eklund, Kilts, Loosen, & Vale, 1984). Furthermore, CRH mRNA is markedly 
increased in the PVN of major depressives (Raadsheer, Van Heerikhuizen, Lucassen, 
Tilders, & Swaab, 1995) and the numbers of CRH immunoreactive neurons and the 
numbers and of CRH neurons that co-express AVP are strongly increased in depressed 
patients (Raadsheer, Hoogendijk, Stam, Tilders, & Swaab, 1994c; Swaab 1997). Several 
mechanisms may be involved in the hyper-activation of these neurons in depression 
including excessive stimulatory input from sensitized limbic or brainstem neurons, 
reduced input from inhibitory circuits, or intrinsic changes in CRH neurons such as 
reduced glucocorticoid receptor function in CRH neurons (De Kloet et al., 1997) or 
altered efficacy of efferent signal transfer to CRH neurons. 
7. I M M U N E ACTIVATION I N D U C E D H P A C H A N G E S A N D 
D E P R E S S I O N 
Several of the long-lasting immune stimulus induced alterations found in rats are 
also seen in depressed patients (see Table 2). As outhned above, alterations at these 
levels are most probably instrumental for the sensitization of the HPA system as 
seen in both conditions. Therefore, we hypothesize that in humans as in rats, transient 
activation of the immune system may result in a period of HPA sensitization and 
changes in CRH neurons. During this period of HPA sensitization, the ACTH and Cor-
tisol responses to internal or external stimuli are supposedly enhanced and therefore 
this period reflects a state of increased vulnerability to stressors. Based on animal 
Table 2. Long-lasting immune stimulus induced and depression associated changes in the 
HPA system. Note the similarities of alterations at hypothalamic and pituitary levels, but not 
at the level of the adrenal gland (for details see text) 
Variables Long-lasting immune induced Depression associated 
AVP expression in CRH neurons T T 
CRH expression in CRH neurons -^/t T 
AVP/CRH signal T T 
Pituitary response to CRH i i 
Pituitary response to AVP T ? 
Glucocorticoid feedback i i 
Resting cortisol/corticosterone levels —> T 
Adrenal response to ACTH -^ T 
Adrenal mass -^ t 
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Studies, we propose that this vulnerable state in humans is also transient, and will fade 
after some time, that is if no major second event occurs within this time domain. During 
this vulnerable period, CRH neurons and pituitary corticotrophs may show functional 
changes but these do not lead to altered resting Cortisol levels and readjust by the end 
of this period of stress sensitization. Although sensitization (Antelman et al., 1989) and 
increased Cortisol responses may be advantageous in some conditions, they represent 
a risk factor for the development of pathology (Munck, McGuire, & Holbrook, 1984; 
De Kloet & Joels, 1996; De Kloet et al., 1997). If during the period of stress sensiti-
zation the individual faces another sensitizing stimulus (immune or otherwise), the 
exaggerated HPA response may be followed by further alterations in CRH neurons 
and pituitary corticotrophs, further increasing the individual's vulnerability to stressors, 
as depicted in Fig 4. Therefore, immune activation induced sensitization of the stress 
response can be considered to represent a premorbid state. By cumulation or kindling 
like mechanisms, these reversible alterations may be driven into a more persistent 
mode during which the changes are accompanied by elevated resting Cortisol levels and 
adrenal hyperactivity. According to this scenario, it can be predicted that the exact 
timing of stressors relative to the immune activation induced stress vulnerable period 
is crucial for the development of adrenal hyperplasia and hyperactivity. 
We do not imply that this cascade of events is specifically activated by immune 
stimuli. In fact, major stimuli of other nature (e.g. loss of spouse) can precipitate 
depression in vulnerable individuals. Nonetheless, we propose that in humans as in 
rodents, immune stimuli may be particularly powerful triggers to induce long-lasting 
cross-sensitization to stimuli of a different nature and thereby represent a risk factor 
for the development of depression. Several observation indicate that immune activa-
tion may relate to a specific form of depression. 
For instance, multiple sclerosis patients show increased (re)activity of hypothal-
PATHOLOGICAL 
STATE 
Figure 4. Long-lasting sensitization and its proposed role in the development of psychopathology. Transient 
activation of the immune system (first arrow) leads to transient activation of the HPA system (thin hne), 
which is followed by a period of adaptive changes in the biological substrate and stress sensitization (bold 
line). During this period, resting plasma levels of ACTH and Cortisol are not affected but hormone responses 
to other stimuli (second arrow) are exaggerated. This will result in further alterations in the neuroendocrine 
substrate and prolonged and/or increased stress vulnerability. When additional stimuli follow within the 
period of stress sensitization, a pathologic state can be reached during which adrenal Cortisol production 
becomes chronically activated. For details see text. 
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amic CRH neurons as indicated by increased numbers of CRH expressing neurons and 
an increase in the fraction of these neurons that co-express AVP (Erkut, Hofman, 
Ravid, & Swaab, 1995; Purba, Raadsheer, Hofman, Ravid, Polman, Kamphorst, & 
Swaab, 1995; Swaab, 1997). Detailed cHnical studies revealed subtle HPA dysregula-
tions e.g. increased resting Cortisol levels (Grasser, Moller, Backmund, Yassouridis, & 
Holsboer, 1996; Michelson, Stone, Galliven, Magaikou, Chrousos, Sternberg, & Gold, 
1994) and blunted responses to CRH (Michelson et al., 1994) and AVP challenge tests 
(Wei & Lightman, 1997). These dysregulations in the HPA system show similarities but 
are not identical with those found in major depression indicating that partly distinct 
processes underlie these distortions. Accordingly, major depression is not likely to occur 
more often in multiple sclerosis patients as compared to the average population, but 
depressive symptoms categorized as depression due to general medical condition are 
frequently found in these patients (up to 50% lifetime risk, Schubert & Foliart, 1993). 
In addition, studies on first degree relatives of MS patients show that the genetic basis 
of depression in these patients is clearly different from that in major depression 
(Sadovnick, Remick, Allen, Swartz, Yee, Eisen, Farquhar, Hashimoto, Hooge, 
Kastrukoff, Morrison, Nelson, Oger, & Paty, 1996) supporting the view that other 
mechanisms, i.e., immune activation induced events, may play a role in MS associated 
depression. 
Another example refers to aging. In elderly populations, a high incidence of minor 
depression and depressive symptoms has been found and a low prevalence of major 
depression (Ernst, 1997). Evidence has been reported to show that the onset and 
remittance of depression is not related with age per se, but rather with physical illness, 
functional impairment and numbers of infectious and other disease episodes 
(Beekman, Kriegsman, Deeg, & Van Tilburg, 1995a; Beekman, Deeg, Smit, & Van 
Tilburg, 1995b). This points to the potential relevance of episodes of immune activa-
tion in the development of vulnerability for depression in the elderly. Interestingly, 
aging is associated with dysregulations of the HPA system (Huizenga, Koper, De Lange, 
Pols, Stolk, Grobbee, De Jong, & Lamberts, 1998). Studies on post mortem brains 
showed that aging is associated with indices of increased (re)activity of hypothalamic 
CRH neurons (increased numbers of CRH expressing neurons, increased fraction of 
vasopressin coproducing CRH neurons (Raadsheer et al., 1993, 1994b, Raadsheer, 
Oorschot, Verwer, Tilders, & Swaab, 1994a). Taken together, these findings support 
the notion that infections or inflammatory episodes that increase with age may 
induce cumulative long-lasting alterations in hypothalamic CRH neurons that are 
associated with sensitization to stressors and represent a risk factor for the develop-
ment of depression. 
It should be noted that CRH neurons may play a role in depression by 
mechanisms other than those mediated by adrenal steroids. Studies with experimental 
animals show that symptoms resembling those seen in depression can be induced by 
intra-cerebral administration of CRH and are mediated by CRH receptors in various 
brainstructures (Chalmers, Lovenberg, Grigoriadis, Behan, & De Souza, 1996). Simi-
larly, transgenic mice overproducing CRH show depression related phenotype 
(Stenzel-Poore, Heinrichs, Rivest, Koob, & Vale, 1994), whereas CRH deficient and 
CRH receptor deficient models show suppression of such symptoms (Muglia, 
Jacobson, & Mazjoub, 1996; Smith, Aubry, Dellu, Contarino, Bilezikjian, Gold, Chen, 
Marchuk, Hauser, Bentley, Sawchenko, Koob, Vale, & Lee, 1998). Since CRH neurons 
are known to project to various brain regions including autonomic motor, sensory, and 
limbic structures, it is conceivable that altered responsiveness of hypothalamic CRH 
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neurons affect mood, cognition, and behavior. Following this line of reasoning infec-
tion, inflammation, surgery, and other immune challenges may induce neuroplastic 
changes that are associated with increased power and responsiveness of CRH neurons 
that may play a role in stress sensitization and consequently in the etiology of mood 
disorders. In this vein, strategies directed to prevent or correct immune activation 
induced long-lasting sensitization and neuroplasticity may prove beneficial. 
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